The COVID-19 pandemic drove huge shifts in clinical trial practice and the transformation is expected to continue even after the global health emergency abates. Industry leaders sharing their predictions around clinical development homed in on decentralized trials, digitization and data tools as key topics for 2022. Read here what our CEO, Colin Hill had to say on the increasing accuracy and applicability of virtual trials in key therapeutic areas including cancer.